MYC and cancer: Our results show that ribosome stalling during heightened cMyc translation and the up-regulated expression of translation factors such as ABCE1 by cMyc present vulnerabilities in cMyc-driven cancers that can be targeted by Nsp1 through the ZNF598 RQC pathway.